No Data
No Data
Cara Jumps on All-stock Merger Deal With Tvardi
Shareholder Alert: Ademi LLP Investigates Whether Cara Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders
Express News | Cara Therapeutics Inc - Imran Alibhai to Serve as CEO of Combined Company
Express News | Trading Halt: Halt Status Updated at 7:25:00 AM ET: Quotation Resumption: News and Resumption Times
Cara Therapeutics Subsidiary to Merge With Tvardi Therapeutics in All-Stock Deal
Cara Therapeutics: Also Enters Into an Asset Purchase Agreement With Vifor Fresenius Medical Care Renal Pharma >CARA
NercZ24 : I bought .261